Loopbaan van Kristie Wagner
Eerdere bekende functies van Kristie Wagner
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01-11-2013 | 01-02-2021 |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Comptroller/Controller/Auditor | 01-06-2021 | - |
| Financieel Directeur/CFO | 24-02-2022 | - |
Opleiding van Kristie Wagner
| Suffolk University | Masters Business Admin |
| Massachusetts College of Liberal Arts | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
| Masters Business Admin | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Entasis Therapeutics Holdings, Inc.
 Entasis Therapeutics Holdings, Inc. BiotechnologyHealth Technology Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections. Its anti-infective discovery platform has produced a pipeline of differentiated programs, which is bacterial infections, including ETX2514SUL (targeting Acinetobacter baumannii infections), ETX0282CPDP (targeting Enterobacteriaceae infections), Non-Beta-lactam PBP inhibitor, and Zoliflodacin. The company was founded in May 2015 and is headquartered in Waltham, MA. | Health Technology |
- Beurs
- Insiders
- Kristie Wagner
- Ervaring
